Velocity Pharmaceutical Development is Biotechnology in United States that focus on Provider business. Founded in 2011. They cover business area such as Provider, drug development service, each new drug candidate, purchase, these candidate, a cost-efficient model, their development, clinical proof, concept, biotechnology company, pharmaceutical company, academia.
2011
( 13 years old in 2024 )
Provider
-
400 Oyster Point Boulevard
Suite 202
South San Francisco, CA 94080
United States
Private
Providerdrug development serviceeach new drug candidatepurchasethese candidatea cost-efficient modeltheir developmentclinical proofconceptbiotechnology companypharmaceutical companyacademia
* We use standard office opening hours in near Velocity Pharmaceutical Development's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Velocity Pharmaceutical Development is Biotechnology business from United States that founded in 2011 (13 years old in 2024), Velocity Pharmaceutical Development business is focusing on Provider.
Velocity Pharmaceutical Development headquarter office and corporate office address is located in 400 Oyster Point Boulevard Suite 202 South San Francisco, CA 94080 United States.
Velocity Pharmaceutical Development was founded in United States.
In 2024, Velocity Pharmaceutical Development is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Velocity Pharmaceutical Development, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
